Grünenthal (Central Europe)

Grünenthal (Central Europe) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Grünenthal (Central Europe) General Information

Description

A portfolio of 14 own and licensed brands for central Europe. The products include Tramal, Zaldiar, Transtec and Palexia sold in the contract area in Czech Republic, Croatia, Hungary, Poland, Romania, Serbia, Slovakia, Slovenia and Ukraine.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Primary Office
  • Zieglerstraße 6
  • 52078 Aachen
  • Germany
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Grünenthal (Central Europe) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Grünenthal (Central Europe)‘s full profile, request access.

Request a free trial

Grünenthal (Central Europe) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Grünenthal (Central Europe)‘s full profile, request access.

Request a free trial